Detalles de la búsqueda
1.
Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammation.
J Pharmacol Exp Ther;
330(2): 377-88, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19478133
2.
Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer.
Mol Cancer Ther;
2(10): 1011-21, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14578466
Resultados
1 -
2
de 2
1
Próxima >
>>